trending Market Intelligence /marketintelligence/en/news-insights/trending/sVE-d6lk7uUdw5E98oxA7A2 content esgSubNav
In This List

Phibro Animal Health acquires microbial-products maker Osprey Biotechnics

Case Study

Identifying PPE Suppliers During the Pandemic

Blog

Highlighting the Top Regional Aftermarket Research Brokers by Sector Coverage

Video

COVID-19 Impact & Recovery: Healthcare Outlook for H2 2021

Blog

Corporate Credit Risk Trends in Developing Markets: A Loss Given Default (LGD) Perspective


Phibro Animal Health acquires microbial-products maker Osprey Biotechnics

Phibro Animal Health Corp. acquired Osprey Biotechnics Inc., a Sarasota, Fla.-based privately held maker of microbial products.

The deal will allow Phibro to benefit from Osprey's microbial strain portfolio, which can be used in advancing its animal health products, as well as agricultural goods such as seed coatings.

Teaneck, N.J.-based Phibro, which provides animal health products such as vaccines, expects the transaction to be accretive to adjusted EBITDA and adjusted diluted EPS for the fiscal year ending June 30, 2020. The company funded the purchase through its existing credit facilities.

The company did not disclose the deal value.